https://www.primmunerx.com/press-releases/primmune-therapeutics-announces-additional-close-of-series-b-financing/
Primmune Therapeutics Announces Additional Close of Series B Financing - Primmune
Jan 26, 2026 - SAN DIEGO, January 26, 2026 – Today, Primmune Therapeutics, a biotech company harnessing the power of the innate immune system, announced an additional close...
additional closeof seriestherapeuticsannouncesb
https://www.bioqubeventures.com/primmune-therapeutics-additional-close-series-b-financing/
Primmune Therapeutics Announces Additional Close of Series B Financing - Bioqube
Feb 7, 2026 - Primmune Therapeutics announces a $23.3M Series B financing to advance a novel TLR7 immunotherapy, into Phase 2 melanoma clinical trials.
additional closeof seriestherapeuticsannouncesb